Fermenta Biotech Ltd - 506414 - Partial Resumption Of Operations At Company'S Factory At Kullu, Himachal Pradesh.
We wish to inform you that the operations of Company''s factory at Kullu, Himachal Pradesh have partially resumed since July 21, 2023. Fermenta Biotech Ltd - 506414 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the Company has received an intimation from its Registrar and Transfer Agent- Link Intime Private Limited on July 18, 2023 regarding issue of duplicate share certificate to the shareholder. Fermenta Biotech Ltd - 506414 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to provisions of Regulation 74(5) of SEBI (Depositories and Participants), regulations 2018, for the quarter ended June 30, 2023, we hereby certify that on receipt of securities for dematerialization- a. The securities comprised in the said certificate of security have been listed on the stock exchanges where the earlier securities are listed. b. The said certificates after due verification have been mutilated and cancelled and the name of the depositories have been substituted in the register of members as the registered owner. The above is confirmed based on the certificate received from our Registrar and Share transfer agent- Link Intime India Private Limited, which is enclosed herewith. Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Strikes /Lockouts / Disturbances
This is to inform you that in view of the natural calamity i.e. heavy rainfall in Himachal Pradesh, the operations of the Company''s facility situated at Kullu, Himachal Pradesh, India are stopped completely since July 10, 2023. Fermenta Biotech Ltd - 506414 - Closure of Trading Window
Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, Company''s Code of Conduct for Prevention of Insider Trading and BSE Circular no. LIST/COMP/01/2019-20 dated April 2, 2019 regarding intimation for Closure of Trading Window, it is hereby notified that the '' Trading Window'' i.e. Period for trading in Company''s Securities will be closed with effect from July 01, 2023 till 48 hours after the declaration of financial results for the quarter ended June 30, 2023 as may be approved at the concerned Board Meeting. During the closure of Trading Window, all Directors, promoters, insiders, Designated Persons including Auditors shall not directly or indirectly trade or deal or enter into any transaction involving sale or purchase of the Company''s equity shares, either in their own name or in the name of their immediate relatives. The intimation regarding the Board Meeting date will be announced in due course. Fermenta Biotech Ltd - 506414 - Intimation Of Investor Presentation - June 2023
Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby enclose a copy of Investor Presentation for June 2023 for your information. The said Investor Presentation will thereafter be uploaded on Company's website at www.fermentabiotech.com Fermenta Biotech Ltd - 506414 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the Company has received an intimation from its Registrar and Transfer Agent - Link Intime India Private Limited on June 14, 2023 regarding issue of duplicate share certificate to the shareholder. Fermenta Biotech Ltd - 506414 - Intimation Of The Allotment Of 1,50,75,318 Equity Shares
This is further to our communication dated May 24, 2023 regarding the Composite Scheme of Amalgamation and Arrangement amongst DVK Investments Private Limited ('Transferor Company 1') and Aegean Properties Limited ('Transferor Company 2') and Fermenta Biotech Limited ('Transferee Company') and their respective Shareholders under sections 230 to 232 of the Companies Act, 2013, sanctioned by the Hon''ble National Company Law Tribunal, Mumbai Bench ('Tribunal') without any modification vide its order dated May 08, 2023 ('Order') and intimation for Record Date of June 02, 2023. Accordingly, pursuant to the aforesaid Scheme, the Committee of Independent Directors of the Company, on June 3, 2023, has allotted 1,50,75,318 equity shares ('New Equity Shares') of the face value of Rs. 5/- (Rupees Five only) each, fully paid-up, to the members of DVK Investments Private Limited, recognized as on the Record Date of June 02, 2023, as per the share exchange ratio in terms of the Scheme. Fermenta Biotech Ltd - 506414 - Intimation Of Earnings Presentation For Quarter 4 - Financial Year 2022-2023
Further to our intimation dated May 29, 2023 regarding approval of Audited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter and financial year ended March 31, 2023, we hereby enclose a copy of Earnings Presentation for Quarter 4 - Financial Year 2022-2023. The said Earnings Presentation will thereafter be uploaded on Company's website at www.fermentabiotech.com Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation with our intimation given vide our letter dated May 29, 2023, regarding declaration of Audited Financial Results for the quarter and financial year ended March 31, 2023, we are enclosing herewith photocopy of the newspaper publications published in Business Standard, Mumbai on page no. 6 and in Sakal, Mumbai on page no. 2 dated May 30, 2023 for your reference and record.